Development of nanoradiopharmaceuticals by labeling polymer nanoparticles with tc-99m.

Autor: Patricio BF; Laboratory of Nanoradiopharmaceuticals, Nuclear Engineering Institute, Rio de Janeiro, RJ, Brazil., Albernaz Mde S, Patricio BF, Albernaz Mde S, Santos-Oliveira R
Jazyk: angličtina
Zdroj: World journal of nuclear medicine [World J Nucl Med] 2013 Jan; Vol. 12 (1), pp. 24-6.
DOI: 10.4103/1450-1147.113946
Abstrakt: Nanomedicine is considered as the future of modern medicine. Hence, serious global efforts are being made for the development of nanopharmaceuticals. Among all the nanopharmaceuticals developed so far, radiopharmaceuticals constitute only a very small portion, as noted in the published literature. The procedures for development of nanoradiopharmaceuticals are complex. In this paper we discuss the results of a research directed at developing nanoradiopharmaceuticals based on three different types of nanopharmaceuticals as alternative drug delivery systems.
Databáze: MEDLINE